These are the posters that Sylentis will present at ARVO-2016. 1-5 MAY SEATTLE .
1*.- Presentation Number - Posterboard Number: 3040 - A0389
Abstract/Presentation Title: Stability study of Bamosiran (a siRNA compound) in ophthalmic solution in different containers .
Session Number: 314
Session
Title: Glaucoma Clinical studies / Pharmacology Session Date/
Times: May 3, 2016 from 8:30 AM to 10:15 AM
***************************************
2*.- Presentation Number - Posterboard Number: 3023 - A0372
Abstract/Presentation Title: Results of Phase IIB SYLTAG clinical trial with bamosiran in patients with glaucoma .
Session Number: 314
Session Title: Glaucoma Clinical studies / Pharmacology
Session Date/ Times: May 3, 2016 from 8:30 AM to 10:15 AM.
***************************************
3*.- Presentation Number - Posterboard Number: 2878 - A0087
Abstract/Presentation Title: Results of clinical trials with a novel RNA-based therapy (SYL1001) to treat patients with ocular pain associated to dry eye disease.
Session Number: 310
Session Title: Dry Eye II
Session Date/ Times: May 3, 2016 from 8:30 AM to 10:15 AM